We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Promega has a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression,... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Diagnosis of Ovarian Cystic Granulosa Cell Tumors Investigated

By LabMedica International staff writers
Posted on 07 Dec 2022
Print article
Image: Histopathology of Granulosa Cell Tumor of the Ovary: the microfollicular pattern was present focally (Photo courtesy of Dr. Edward Uthman MD)
Image: Histopathology of Granulosa Cell Tumor of the Ovary: the microfollicular pattern was present focally (Photo courtesy of Dr. Edward Uthman MD)

Granulosa cell tumors (GCTs) of both juvenile (JGCT) and adult (AGCT) types may sometimes be completely or predominantly cystic. Interest in this subset of neoplasms has largely been related to their higher frequency of association with androgenic manifestations compared with their typical counterparts.

There is the tendency for cystic tumors to account for a disproportionate number of androgenic GCTs. However, most of the issues associated with these tumors from the perspective of the pathologist relate to their differential diagnosis with a variety of other cystic lesions. The challenge is often significant, in part because of overlapping gross features, but also because of frequent denudation or flattening of the lining epithelium that may impart a non-diagnostic appearance in many areas.

Pathologists at the Massachusetts General Hospital (Boston, MA, USA) and their international colleagues identified 80 cystic GCTs were from their consultation files and the archives of their institution between 1960 and 2020, including eight reported in a prior study. Tumors were included in this study only when the cyst lining was smooth or, at most, slightly granular; tumors with any intracystic solid component were excluded. From two to 28 (average, eight) hematoxylin and eosin–stained slides of tumor were available for review.

Five AGCTs with available material underwent FOXL2 mutation analysis. DNA extractions were performed with a Maxwell RSC DNA FFPE kit on a Maxwell RSC device (Promega, Madison, WI, USA). DNA was quantified using Promega QuantiFluor ONE dsDNA System. Sequencing reactions were carried out on the ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).

The scientists reported that the great majority of the cyst linings in the 24 AGCTs had areas of denudation ranging from minimal to moderate to extensive (>90% denudation in seven). All tumors were greater than 8 cm (average, 17 cm) with minimal to absent gross solid component. Denudation of cells lining the cysts was prominent. Invagination of the epithelium into the cyst walls was a key diagnostic feature, was present as cords, trabeculae, solid nests, and small and large follicles, and was identified in most tumors (17 AGCTs and 45 JGCTs). Cytologic atypia was essentially absent in AGCTs, whereas 14 JGCTs showed moderate to severe atypia of bizarre type. A theca cell component was present in all tumors and was extensive in 54. A FOXL2 hotspot mutation was identified in 1/4 AGCTs tested.

The authors concluded that despite extensive denudation, the finding of typical architectural patterns and cytologic features as well as, in some cases, androgenic manifestations helps differentiate cystic GCTs from follicle cysts, the most common and challenging differential diagnosis, as well as other cystic neoplasms that may enter the differential diagnosis. FOXL2 sequencing may show a false-negative result in cystic AGCT because of the limited number of cells present within the tumor sample. The study was published in the December 2022 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
Massachusetts General Hospital
Applied Biosystems

Flocked Swab
HydraFlock and PurFlock Ultra
Platinum Supplier
Ultra-Low PSA Control
Prostate-Specific Antigen Control
3 Part Diff Auto Hematology Analyzer
Gold Supplier
CLIA Analyzer

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: The Geo portable testing platform integrated with the Snap collection device (Photo courtesy of ReadyGo Diagnostics)

Ultra-Portable Rapid Test Platform Offers Complete Sample-to-Answer Solution for Remote and Off-Grid Testing

An ultra-portable isothermal molecular diagnostics system integrated with a patented device which combines sample collection and processing into a single, easy-to-use disposable is set to revolutionize... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

Hemoglobin A1c (HbA1c), or glycated hemoglobin, refers to hemoglobin with glucose attached. HbA1c testing devices are used for blood tests that determine average blood glucose, or blood sugar levels.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.